Role of CYP3A4 in Human Hepatic Diltiazem N-Demethylation: Inhibition of CYP3A4 Activity by Oxidized Diltiazem Metabolites
Authors:
- Alison M. ButlerABAlison M. Butler
- Louise NadinLNLouise Nadin
- Michael MurrayMMMichael Murray
- 1 July 1997
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 282 (1) , 294-300
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Determination of diltiazem and its main metabolites in human plasma by automated solid-phase extraction and high-performance liquid chromatography: a new method overcoming instability of the compounds and interference problemsJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Simple and sensitive high-performance liquid chromatographic method for the determination of diltiazem and six of its metabolites in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver.Proceedings of the National Academy of Sciences, 1989
- Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzymeArchives of Biochemistry and Biophysics, 1988
- Acute and chronic studies of diltiazem in elderly versus young hypertensive patientsThe American Journal of Cardiology, 1987
- Drug metabolism in cirrhosisBiochemical Pharmacology, 1986
- Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamilBiochemical Pharmacology, 1985
- Inhibition and enhancement of mixed-function oxidases by nitrogen heterocyclesBiochemical Pharmacology, 1982
- [39] Direct fluorometric methods for measuring mexed-function oxidase activity1978
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951